Clinical Trials

Breast Neoplasm Female

NCT03096418 2026-01-16

Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response

Phase 4 Recruiting

50 enrolled 12 charts

Breast Neoplasm Female

NCT04113863 2025-12-18

ATRA

Phase 2 Terminated

76 enrolled

Phase NA Not yet recruiting

Breast Neoplasm Female

NCT07180433 2025-09-18

Piloting 18F-FAPI PET/MRI for Applications in Breast Cancer

60 enrolled

Breast Neoplasm Female

NCT05071105 2025-05-30

SBRT in Early Breast Cancer in Elderly Women

Phase NA Recruiting

30 enrolled

Breast Neoplasm Female

NCT06258863 2025-03-17

Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery

Enrolling by invitation

300 enrolled

Phase 1 Active not recruiting

Breast Neoplasm Female

NCT03900884 2024-11-07

PALVEN

17 enrolled

Breast Neoplasm Female

NCT05027321 2024-09-19

Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies

Phase NA Recruiting

100 enrolled

Breast Neoplasm Female

NCT06499077 2024-07-12

BreathBC

Active not recruiting

1,000 enrolled

Breast Neoplasm Female

NCT05574816 2024-06-12

Phi-Bra

45 enrolled

Breast Neoplasm Female

NCT03673150 2024-05-17

SEINPOL

Completed

268 enrolled

Breast Neoplasm Female

NCT06080607 2024-03-25

PRO

Recruiting

280 enrolled

Breast Neoplasm Female

NCT06234137 2024-01-31

neoPICD

Phase NA Recruiting

154 enrolled

Breast Neoplasm Female

NCT06102018 2023-10-26

Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine

150 enrolled

Breast Neoplasm Female

NCT03592771 2023-09-05

THRIVE

304 enrolled 18 charts

Breast Neoplasm Female

NCT05969184 2023-08-01

Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC

Phase 2 Unknown

94 enrolled

Breast Neoplasm Female

NCT04750889 2023-06-18

RFID

Completed

80 enrolled

Breast Neoplasm Female

NCT05600153 2022-10-31

AvBSR

Phase NA Unknown

136 enrolled

Breast Neoplasm Female

NCT03662633 2022-10-20

Diagnosis Value of SEMA4C in Breast Cancer

2,300 enrolled

Breast Neoplasm Female

NCT05577442 2022-10-19

Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer

Phase 2 Unknown

52 enrolled

Breast Neoplasm Female

NCT05140655 2021-12-01

Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-

40 enrolled

Breast Neoplasm Female

NCT05075512 2021-10-12

The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer

Phase 2 Recruiting

40 enrolled

Breast Neoplasm Female

NCT03501121 2021-10-06

TARGIT-X

714 enrolled

Breast Neoplasm Female

NCT04811378 2021-09-13

HaemoCerTM Application in Breast Cancer Surgery

136 enrolled

Breast Neoplasm Female

NCT04927130 2021-06-25

Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast Cancer

150 enrolled

Breast Neoplasm Female

NCT03117894 2021-06-04

PECS-2 for Breast Surgery

200 enrolled

Breast Neoplasm Female

NCT03198442 2020-03-24

Breast PET

12 enrolled

Breast Neoplasm Female

NCT03638414 2018-08-20

ePainQ

Phase NA Unknown

25 enrolled

Breast Neoplasm Female

NCT02957526 2018-07-19

AETAPP

44 enrolled

Breast Neoplasm Female

NCT03575845 2018-07-03

The Effect of Yoga on Barriers to Occupational Engagement in African American Breast Cancer Survivors

17 enrolled

Breast Neoplasm Female

NCT03069885 2018-05-02

iNPWT in Immediate Breast Reconstruction

Phase NA Unknown

60 enrolled

Breast Neoplasm Female

NCT03217539 2018-02-07

WE

133,065 enrolled

Breast Neoplasm Female

NCT03011060 2017-01-10

NACVCAC

Phase 3 Unknown

1,588 enrolled